Wang et al. investigated the role of PKM2 in GC, and it was discovered that there is an overexpression of the protein in GC patients and that this overexpression was linked to poor prognosis and clinicopathologic parameters of the disease [189]. The gene discussed is PKM; the disease is gastric cancer.